Tokyo, Japan

Toshiyasu Imai

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Saitama, JP (2016 - 2018)
  • Tokyo, JP (2018 - 2022)
  • Misato, JP (2013 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Toshiyasu Imai: Innovator in Medicinal Chemistry

Introduction

Toshiyasu Imai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutics. With a total of 17 patents to his name, Imai's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Imai's latest patents include a medicament for treating cough, which features a compound that acts as a P2X4 receptor antagonist. This invention aims to provide an effective solution for preventing or treating coughs. Another notable patent involves a diazepine derivative that serves as a P2X4 receptor antagonist, showcasing Imai's innovative approach to drug development.

Career Highlights

Throughout his career, Toshiyasu Imai has worked with notable organizations such as Nippon Chemiphar Co., Ltd. and Kyushu University. His experience in these institutions has allowed him to refine his expertise in medicinal chemistry and contribute to groundbreaking research.

Collaborations

Imai has collaborated with esteemed colleagues, including Shogo Sakuma and Kazuhide Inoue. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of medicine.

Conclusion

Toshiyasu Imai's contributions to medicinal chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…